Bibliographic Details
| Title: |
Efficacy of low-dose oral metronomic dosing of the prodrug of gemcitabine, LY2334737, in human tumor xenografts. |
| Authors: |
Pratt SE; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA. Pratt_Susan_E@lilly.com, Durland-Busbice S, Shepard RL, Donoho GP, Starling JJ, Wickremsinhe ER, Perkins EJ, Dantzig AH |
| Source: |
Molecular cancer therapeutics [Mol Cancer Ther] 2013 Apr; Vol. 12 (4), pp. 481-90. Date of Electronic Publication: 2013 Jan 31. |
| Publication Type: |
Journal Article |
| Journal Info: |
Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
